AKT1

Level: Level 1A

Description:

v-akt murine thymoma viral oncogene homolog 1 [Source:HGNC Symbol;Acc:391]

Other Names: RAC, PKB, PRKBA, AKT, RAC-alpha, AKT1
Overview
Ensembl ID | ENSG00000142208
Transcript ID | ENST00000554581
Gene position | 14:105235686-105262088
Cytoband | 14q32.33
NCBI | 207
HGNC Id | 391
Refseq ID | NM_005163
Related Link
CCDS ID | CCDS9994
Uniprot ID | P31749
UCSC ID | uc001ypm.4
OMIM ID | 164730
CIViC ID | 2
OncoKB | AKT1
Pharos | AKT1
Gene info
Gene Type | protein-coding gene
Protein family | Pleckstrin homology domain containing;AKT kinases
Pathway(KEGG) | AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Diabetic cardiomyopathy, Dopaminergic synapse, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, Glucagon signaling pathway, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Measles, Melanoma, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Protein kinases, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway,
Pathway(Rectome) | AKT phosphorylates targets in the cytosol, AKT phosphorylates targets in the nucleus, AKT-mediated inactivation of FOXO1A, Activation of BAD and translocation to mitochondria, Activation of BH3-only proteins, Adaptive Immune System, Apoptosis, Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA, CD28 dependent PI3K/Akt signaling, Cell Cycle, Cell Cycle, Mitotic, Cellular response to chemical stress, Cellular responses to mechanical stimuli, Cellular responses to stimuli, Cellular responses to stress, Co-inhibition by CTLA4, Co-stimulation by CD28, Constitutive Signaling by AKT1 E17K in Cancer, Cyclin A:Cdk2-associated events at S phase entry, Cyclin E associated events during G1/S transition, Cytokine Signaling in Immune system, Deactivation of the beta-catenin transactivating complex, Developmental Biology, Disease, Diseases of signal transduction by growth factor receptors and second messengers, Downregulation of ERBB2 signaling, Downregulation of ERBB2:ERBB3 signaling, ESR-mediated signaling, Estrogen-dependent nuclear events downstream of ESR-membrane signaling, Extra-nuclear estrogen signaling, FLT3 Signaling, FOXO-mediated transcription, G beta:gamma signalling through PI3Kgamma, G-protein beta:gamma signalling, G1/S Transition, GPCR downstream signalling, Gene expression (Transcription), Generic Transcription Pathway, Hemostasis, High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells, Immune System, Infectious disease, Integrin signaling, Interleukin-4 and Interleukin-13 signaling, Intracellular signaling by second messengers, Intrinsic Pathway for Apoptosis, KEAP1-NFE2L2 pathway, KSRP (KHSRP) binds and destabilizes mRNA, MTOR signalling, Mechanical load activates signaling by PIEZO1 and integrins in osteocytes, Membrane Trafficking, Metabolism, Metabolism of RNA, Metabolism of cofactors, Metabolism of nitric oxide: NOS3 activation and regulation, Metabolism of vitamins and cofactors, Mitochondrial unfolded protein response (UPRmt), Mitotic G1 phase and G1/S transition, Negative regulation of NOTCH4 signaling, Negative regulation of the PI3K/AKT network, PI3K/AKT Signaling in Cancer, PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling, PIP3 activates AKT signaling, PTEN Regulation, PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1, Platelet Aggregation (Plug Formation), Platelet activation, signaling and aggregation, Programmed Cell Death, RAB GEFs exchange GTP for GDP on RABs, RNA Polymerase II Transcription, RUNX2 regulates genes involved in cell migration, Rab regulation of trafficking, Regulation of PTEN stability and activity, Regulation of T cell activation by CD28 family, Regulation of TP53 Activity, Regulation of TP53 Activity through Acetylation, Regulation of TP53 Activity through Association with Co-factors, Regulation of TP53 Degradation, Regulation of TP53 Expression and Degradation, Regulation of beta-cell development, Regulation of gene expression in beta cells, Regulation of localization of FOXO transcription factors, Regulation of mRNA stability by proteins that bind AU-rich elements, Response of endothelial cells to shear stress, S Phase, SARS-CoV Infections, SARS-CoV-2 Infection, SARS-CoV-2 targets host intracellular signalling and regulatory pathways, SARS-CoV-2-host interactions, Signal Transduction, Signaling by ERBB2, Signaling by GPCR, Signaling by Interleukins, Signaling by NOTCH, Signaling by NOTCH4, Signaling by Non-Receptor Tyrosine Kinases, Signaling by Nuclear Receptors, Signaling by PTK6, Signaling by Receptor Tyrosine Kinases, Signaling by VEGF, Signaling by WNT, TCF dependent signaling in response to WNT, TP53 Regulates Metabolic Genes, Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation, Transcriptional Regulation by TP53, Transcriptional regulation by RUNX2, Translocation of SLC2A4 (GLUT4) to the plasma membrane, VEGFA-VEGFR2 Pathway, VEGFR2 mediated vascular permeability, Vesicle-mediated transport, Viral Infection Pathways, eNOS activation,
Pathway(Uniprot) | /
Description

FUNCTION: AKT1 is one of 3 closely related serine/threonine- protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)- response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr- 117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation. Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation. Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD stimulates its pro- apoptotic activity. Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53.

Gene Class

  • Role in Cancer Oncogene
  • Essential Gene /
  • Cell Senescence Gene CSGene
  • Type of Senescence Oncogene-induced
  • Regeneration Gene REGene

Evidence Source

  • Clinical CIViC
  • Validate NCG;OncoKB;CGC T1
  • Literature ONGene;CancerMine;SEECancer
  • Experimental CCGD Rank B
  • Predict CnCs-calculator T1;NCG predicted

Gene Essential Source

  • Essential Gene E
  • CRISPR N
  • CRISPR2 N
  • Gene-Trap N
  • Gene Indispensability Score 0.994122745
  • Gene Indispensability E

Gene Damage Prediction

  • All Disease-causing Medium
  • All Mendelian Disease-causing Medium
  • All PID Disease-causing Medium
  • All Cancer Disease-causing Medium
  • Cancer Recessive Disease-causing Medium
  • Cancer Dominant Disease-causing Medium
GO annotation
Cancer Associated Splicing Events (CASE)
Method Classification
  • Evolutionary selective pressure(dN/dS) based: CN/CS-calculator dNdScv CBaSE
  • Mutation frequency based: MuSiC MuSig2CV OncodriveCLUST
  • Feature(e.g. functional impact) based: 20/20+ CompositeDriver OncodriveFML
  • Structural(Domain) based: e-Driver ActiveDriver
  • Omic/Network or pathway based: DriverNet
  • Machine learning based: DawnRank
  • Result in Pan-cancer
  • dNdSCNCS-calculator;CBaSE;dNdScv
  • FrequencyMuSiC;MutSig2CV;OncodriveCLUST
  • Feature2020plus
  • Domaine-Driver
  • Result in Cancer
Cohort:    Project: